Skip to content

Internet-Based Stress Recovery Program for Adolescents

Internet-Based Stress Recovery Program for Adolescents

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05688254
Acronym
FOREST-A
Enrollment
82
Registered
2023-01-18
Start date
2023-04-25
Completion date
2023-06-30
Last updated
2024-05-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stress, Psychological

Brief summary

The study aims to evaluate the feasibility and efficacy of the internet-based stress recovery program for adolescents.

Detailed description

The FOREST-A is a third-wave cognitive behavioral therapy and mindfulness-based internet-delivered 4-week psychosocial intervention for recovery from stress, which was initially developed for healthcare workers and is now adapted for adolescents. The program comprises six modules: introduction, relaxation, psychological detachment, mastery, control, and summary, with psychologist engagement on-demand. Each module includes psychoeducation and exercises. The program will be delivered in Lithuanian. The intervention will be evaluated using the two-arm randomized controlled trial with intervention and care as usual condition at pre-test and post-test.

Interventions

BEHAVIORALFOREST-A

The internet-based psychosocial intervention will be delivered. The intervention comprises six modules: introduction, relaxation, psychological detachment, mastery, control, and summary, within psychoeducation and exercises in each module. The interactions with psychologists will be on demand. The whole intervention duration will be 4 weeks.

Sponsors

Vilnius University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Participants will be randomly allocated either to the intervention or control groups. The intervention group will use the intervention and the control will take care as usual.

Eligibility

Sex/Gender
ALL
Age
15 Years to 19 Years
Healthy volunteers
Yes

Inclusion criteria

* Recent exposure to life-stressor. * Students of high schools in Lithuania. * Comprehending Lithuanian. * Parental and own consent for minor-aged participants (\< 18 years)/only own consent for adolescents aged 18 years or older to participate in the study provided. * Have access to a device (such as a tablet, phone or computer) with an internet connection.

Exclusion criteria

* Acute psychiatric condition/crisis. * No recent life-stressor exposure, or low levels of stress.

Design outcomes

Primary

MeasureTime frameDescription
The Recovery Experience QuestionnairePre-treatment, post-treatment (after 4 weeks), 3 months follow-upThe Recovery Experience Questionnaire (Sonnentag & Fritz, 2007) adapted Child and Adolescent version will be used to measure the changes in recovery from stress experience. It is a self-report measure comprising 16 items, with provided 5-point Likert scale, ranging from Totally disagree (=1) to Totally agree (=5). Total scores may range from 16 to 80, and higher scores will indicate higher recovery.

Secondary

MeasureTime frameDescription
The Generalized Anxiety Disorder-7 scalePre-treatment, post-treatment (after 4 weeks), 3 months follow-upThe Generalized Anxiety Disorder-7 scale (Spitzer, Kroenke, Williams, & Löwe, 2007) will be used to measure the changes in generalized anxiety symptoms.The measure comprises 7 items with the possible answers ranging on a 4-point Likert scale from Not at all (=0) to Nearly every day (=3). Total scores may range from 0 to 21. Higher scores will indicate higher generalized anxiety symptoms.
The Patient Health Questionnaire-9 questionnairePre-treatment, post-treatment (after 4 weeks), 3 months follow-upThe Patient Health Questionnaire-9 (Löwe, Kroenke, Herzog, & Gräfe, 2004) will be used to measure changes in depressive symptoms. The measure comprises 9 items, with provided a 4-point Likert scale, ranging from Not at all (=0) to Nearly every day (=3). Total scores may range from 0 to 27. Higher scores will indicate higher depressive symptoms.
The Adjustment Disorder New Module-8 Child and Adolescent Version QuestionnairePre-treatment, post-treatment (after 4 weeks), 3 months follow-upThe Adjustment Disorder New Module-8 Child and Adolescent Version (Kazlauskas et al., 2018) will be used to measure the changes in symptoms of adjustment disorder, which are described in the International Classification of diseases 11th edition (WHO, 2018). The measure includes a list of 16 potentially stressful events (with binary answers Yes and No, indicating whether the participant has experienced a stressor) and 8 items for adjustment disorder symptoms evaluation (with a 4-point Likert scale ranging from Never (=1) to Often (=4)). Total scores may range from 8 to 32, and higher scores will indicate higher adjustment problems.
The Perceived Positive Social Support ScalePre-treatment, post-treatment (after 4 weeks), 3 months follow-upThe Perceived Positive Social Support Scale (Kazlauskas et al., 2022) will be used to measure changes in social support. The measure comprises 4 items, with provided an 8-point Likert scale ranging from Never (=0) to Always (=7). Total scores may range from 0 to 28. Higher scores will indicate higher perceived positive support.
The WHO-5 Well-being Index QuestionnairePre-treatment, post-treatment (after 4 weeks), 3 months follow-upThe WHO-5 Well-being Index (Topp, Østergaard, Søndergaard, & Bech, 2015) will be used to measure changes in general psychological well-being. The measure comprises 5 items with a Likert scale ranging At no time (=0) to All of the time (=5). Total scores may range from 0 to 25. Higher scores will indicate better psychological well-being.

Other

MeasureTime frameDescription
Program evaluation questionsPost-treatment (after 4 weeks)Participants will be given questions regarding the usage, general satisfaction, usefulness of the program, and subjective impact on psychological and physical well-being.

Countries

Lithuania

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 9, 2026